QIR Suite vs FFRangio System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
QIR Suite
by CASIS Cardiac Simulation & Imaging Software
VS
FFRangio System
by CathWorks (acquired by Medtronic)

AI Verdict

QIR Suite specializes in AI-driven quantitative analysis of MR and CT images for a broad spectrum of cardiovascular conditions, supporting diagnosis and prognosis. Conversely, the FFRangio System offers wire-free FFR guidance based on angiograms, specifically designed to optimize and confirm PCI decisions for coronary artery disease. While both utilize AI in cardiology, their differing input modalities and clinical applications position them as complementary tools rather than direct competitors.

Choose QIR Suite if…

Choose QIR Suite if your primary need is a comprehensive, AI-powered quantitative analysis of pre-existing cardiac MR and CT images for detailed diagnosis and prognosis of cardiovascular conditions. This tool excels at automatically segmenting heart regions, detecting pathological areas, and quantifying over 100 clinical parameters, including blood flow, pathological volumes, and myocardial strain, to provide deep insights into cardiac function and structure.

View QIR Suite →

Choose FFRangio System if…

Choose FFRangio System if you require real-time, non-invasive physiological guidance during percutaneous coronary intervention (PCI) procedures in the cath lab for patients with coronary artery disease. This system is ideal for quickly obtaining accurate, wire-free, and drug-free 3D FFR results across multiple vessels, enabling clinicians to optimize and confirm PCI decisions efficiently by assessing lesion impact and functional patterns of CAD.

View FFRangio System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature QIR Suite FFRangio System
Pricing Contact for pricing Contact vendor for pricing information.
Deployment Locally on dedicated hardware SaaS, on-prem, hybrid
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature QIR Suite FFRangio System
Name QIR Suite FFRangio System
Company CASIS Cardiac Simulation & Imaging Software CathWorks (acquired by Medtronic)
Description AI-based medical imaging analysis software for cardiovascular conditions, offering quantitative evaluation of MR and CT images to support diagnosis and prognosis. The CathWorks FFRangio System delivers wire-free and drug-free 3D FFR guidance, providing accurate multi-vessel FFR results and advanced insights to quickly optimize and confirm PCI decisions for patients with coronary artery disease.
Key Features AI-based analysis of MR and CT examinations, Detection of heart regions and pathological areas, Quantification of over 100 clinical parameters, Automatic segmentation, Blood flow/velocities quantification, Pathological volumes detection and quantification, Semi-quantification of myocardial perfusion, Strain quantification Real-time FFRangio values at every point on the coronary tree, Simulated pullback curve differentiates functional patterns of CAD, Lesion Impact feature to assess residual ischemia, Integrated sizing tool for non-invasive lesion measurements, Intuitive user interface, Artificial intelligence aids in quick angiogram analysis, Seamless integration with cath lab boom and PACS, Eliminates the need for invasive pressure wires, drugs, or a guide catheter
Specialties Cardiology, Radiology Cardiology

Videos

Demos, reviews, and walkthroughs featuring QIR Suite and FFRangio System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

QIR Suite is an AI-based medical imaging analysis software for cardiovascular conditions, offering quantitative evaluation of MR and CT images to support diagnosis and prognosis. The FFRangio System delivers wire-free and drug-free 3D FFR guidance to optimize and confirm PCI decisions for patients with coronary artery disease.
QIR Suite uses AI-based analysis of MR and CT examinations to detect heart regions, pathological areas, and quantify over 100 clinical parameters. The FFRangio System combines artificial intelligence and advanced computational science to obtain physiologic information from routine angiograms, eliminating the need for invasive pressure wires and drug stimulation.
QIR Suite aims to improve diagnosis and prognosis by providing comprehensive quantitative evaluation of MR and CT images, including automatic segmentation and strain quantification. The FFRangio System aims to replace the need for invasive pressure wires, drugs, or a guide catheter for FFR measurements, streamlining PCI decision-making.
QIR Suite quantifies over 100 clinical parameters, including blood flow/velocities, pathological volumes, semi-quantification of myocardial perfusion, and strain quantification. The FFRangio System provides real-time FFRangio values at every point on the coronary tree, a simulated pullback curve to differentiate functional patterns of CAD, and an integrated sizing tool for non-invasive lesion measurements.
QIR Suite is designed for use in Cardiology and Radiology specialties. The FFRangio System is primarily focused on Cardiology, specifically for interventional cardiologists in the cath lab.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring QIR Suite or FFRangio System

AI Tool Finder
AI-powered search. Results may not be comprehensive.